Skip to Content
Stock Analyst Update

No Reason to Be Leery of Undervalued Calpine

The company's focus on deleveraging should ease investor concerns.


We are reaffirming our $20 fair value estimate, along with our no-moat and positive moat trend ratings, after  Calpine (CPN) reported full-year adjusted EBITDA of $1.815 billion, compared with $1.976 billion in the year-ago period, in line with our estimates. Management reaffirmed adjusted EBITDA guidance range of $1.8 billion-$1.95 billion for 2017, in line with our $1.9 billion estimate. Calpine's 2017 adjusted free cash flow guidance of $710 million-$860 million also is in line with our $798 million estimate.

Management has been slow to deleverage compared with its peers, showing reluctance to commit to specific targets and allowing management more capital allocation flexibility. While we were comfortable with management's plan to allocate capital to both deleveraging and share repurchases, investors clearly remained leery in a commodity sensitive environment. Management's accelerated deleveraging calls for $2.7 billion in debt paydown by 2019, reducing leverage 1.5 times against current adjusted EBITDA levels. Against our forward adjusted EBITDA levels, we see deleveraging nearly 2.0 times by 2019. Our previous estimates called for $2.6 billion in share repurchases and debt paydown. The company's plan to shift capital toward deleveraging has no material impact on our fair value estimate. 

Calpine continues to build out its retail platform, acquiring residential retail provider North American Power for $105 million. This is in addition to recently acquired commercial and industrial retailer Noble Americas Energy Solutions. We continue to appreciate management's retail efforts, as Calpine Energy Solutions should provide a strong hedge to Calpine's generation fleet in a stubbornly low commodity price environment. Management is deploying capital to retail from recent portfolio changes, mainly the sale of Mankato and Osprey.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Andrew Bischof does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.